Product Overview
Nivolumab | T9907 | TargetMol Chemicals
CAS: 946414-94-4
Smiles:
Formula: N/A
Pathway: Apoptosis|||Cell Cycle/Checkpoint|||Immunology/Inflammation
Target: PD-1/PD-L1
Receptor: N/A
Bioactivity: Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Molecular Weight: 146000
